The secretin receptor is a protein that in humans is encoded by the SCTR gene. This protein is a G protein-coupled receptor which binds secretin and is the leading member (i.e., first cloned) of the secretin receptor family, also called class B GPCR subfamily. SCTR belongs to the glucagon-VIP-secretin receptor family; its locus is 2q14.2.
Interactions The secretin receptor has been shown to interact with pituitary adenylate cyclase activating peptide.
Clinical significance
Breast Cancer SCTR neither uniformly upregulated or downregulated in tumors, hence, it has the potential to promote or suppress tumor proliferation. In a study investigating methylation of the SCTR genes in breast cancer tissue, hypermethylation and downregulation were observed; pathway analysis in MCF-10A cells determined these most likely effect the G2/M stage checkpoint. However, SCTR was overexpressed in MCF-7 cells, leading to increased proliferation and migration. The study concluded that SCTR downregulates proliferation in normal breast cells and upregulates proliferation in breast cancer cells that have their proliferation downregulated by promoter methylation.
Colorectal cancer SCTR has been observed to be hypermethylated in colorectal cancer. Moreover, because of the high frequency of hypermethylation at CpG islands in colorectal cancer, SCTR hypermethylation is an effective diagnostic marker that has achieved high diagnostic performance; colorectal cancer and precursor legions were able to be distinguished using SCTR methylation as a diagnostic tool. Additionally, SCTR genes were found to be hypermethylated in cell-free DNA samples of colorectal cancer patients, but not in cells from healthy patients.
References
Further reading
External links IUPHAR GPCR Database - Secretin receptor Archived 2016-03-03 at the Wayback Machine secretin+receptor at the U.S. National Library of Medicine Medical Subject Headings (MeSH)






